查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1840876

腦圖譜儀器- 全球預測（2025-2032 年）

Brain Mapping Instruments Market by Component, Technology, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，腦圖譜儀器市場規模將達到 51.5 億美元，複合年成長率為 14.37%。

關鍵市場統計數據
基準年 2024 17.5億美元
預計年份：2025年 20.1億美元
預測年份 2032 51.5億美元
複合年成長率 (%) 14.37%

全面介紹不斷發展的腦圖譜儀器生態系統，包括硬體、服務、軟體和終端用戶互通性

腦圖譜儀器在神經科學研究、臨床診斷和治療創新領域中發揮著至關重要的作用。目前的研究設備涵蓋了由硬體、服務和軟體組成的複雜生態系統，這些組件共同作用，使臨床醫生和研究人員能夠可視化、量化和解讀跨越多個時空尺度的神經活動。隨著技術能力的不斷提升，這些設備日益成為多模態整合、進階分析和協作工作流程的平台，其應用範圍已超越了單一設備部署。

硬體層包括分析儀、電極、感測器和掃描系統，這些設備必須具備高精度、高可靠性，並與不斷發展的分析流程相容。諮詢、維護和培訓等支援服務透過確保營運的連續性和最大化科研產量，為成功實施奠定了基礎。軟體解決方案涵蓋從分析應用程式到資料管理系統的各種應用，旨在將高維度訊號轉換為可重複的、符合監管要求的輸出結果。

臨床和研究領域的使用者需求多種多樣，但又相互關聯。神經病學、腫瘤學和精神病學需要儀器來輔助診斷和治療監測，而學術研究、認知神經科學和藥物研究則需要靈活的平台來進行假設驅動的實驗和轉化研究。最終用戶，包括學術和研究機構、醫院、診斷中心以及製藥和生物技術公司，各自有不同的採購週期、監管要求和資料管治要求。

綜上所述，這些動態凸顯了儀器發展方向的轉變，即從單一功能儀器轉向可互通、軟體驅動的系統轉變，後者優先考慮資料完整性和生命週期支援。本引言為深入分析技術發展軌跡、供應鏈壓力、監管考量以及策略性舉措奠定了基礎，這些因素將決定哪些解決方案能夠產生臨床和商業性影響。

深入探討技術融合、資料優先平台和服務主導模式如何推動腦圖譜儀器在臨床和研究領域的應用。

小型化、即時分析和人性化的設計技術的進步，正在拓展神經數據的採集地點和方式，從而改變腦圖譜儀器的模式。可攜式和無線腦電圖（EEG）系統使研究能夠在傳統實驗室環境之外進行，重新定義了可及性；而穿戴式式腦磁圖（MEG）和新興的近紅外光譜（NIRS）技術則降低了長期和動態監測的變革時期。這些硬體創新，結合雲端原生資料架構和邊緣分析技術，正在開啟情境神經科學的新時代，在這個時代，以患者和參與者為中心的工作流程將得以大規模實現。

同時，軟體正從孤立的分析軟體套件演變為融合了先進訊號處理、機器學習和安全資料管理的整合平台。分析軟體如今更加重視可復現性、溯源性和合規性，而資料管理系統則需適應更嚴格的隱私權保護要求和聯邦學習模型。因此，諮詢、維護和培訓等服務也日益專注於幫助科研機構運作複雜的儀器設備群，並從高頻資料流中獲得長期價值。

另一個顯著的變化是臨床與研究之間的界線日益模糊。臨床和研究用途的功能性磁振造影（fMRI）工作流程正透過標準化通訊協定和可互通的資料格式逐漸融合，而正子斷層掃描（PET）成像的各種亞型也被整合到多模態研究中，將代謝訊號與電生理和血流動力學測量結果關聯起來。這種融合促進了醫院、學術中心和製藥公司之間更深入的合作，加速了實驗結果轉化為診斷和治療工具的發展。

最後，監管和報銷壓力正在影響產品藍圖。製造商優先考慮那些能夠展現臨床效用並符合支付方和監管機構所採用的證據框架的功能。同時，隨著地緣政治因素影響採購和生產決策，供應鏈韌性和在地化策略變得至關重要。這些因素的綜合作用正在重新定義競爭優勢，使企業能夠憑藉卓越的設備、強大的軟體生態系統和端到端的服務能力脫穎而出。

對近期貿易政策和關稅變化如何改變腦圖譜系統中的供應鏈選擇、採購模式和服務優先事項進行深入分析

關稅制度和貿易政策的變化會對腦成像生態系統產生連鎖反應，影響關鍵組件和完整系統的供應、前置作業時間和成本結構。如果對進口電子產品、感測器和成像子系統徵收關稅，製造商和採購團隊將被迫重新評估其供應鏈，並考慮其他方案以降低進口成本增加的風險。這通常會加速供應商多元化、組件生產近岸化以及增加庫存緩衝等的考量，以確保臨床和研究客戶的業務連續性。

2025年關稅調整的累積影響凸顯了製造佈局和供應商關係的策略重要性。擁有垂直整合能力或本地組裝設施的供應商將具有相對優勢，因為他們可以幫助買家規避運輸相關的不確定性和與海關相關的波動。醫院和研究機構通常資金周轉和採購週期較短，它們可能會調整採購模式，傾向於選擇模組化系統，以便進行逐步升級而非全面更換，從而降低進口關稅上漲帶來的價格敏感度。

關稅也在刺激合約和服務模式的變革。隨著零件成本的上漲，資本支出的合理性論證變得越來越複雜，許多機構將探索基於服務的採購、延長租賃協議以及平台即服務 (PaaS) 等方案，以便在無需承擔全部前期成本的情況下繼續使用尖端儀器。能夠提供全面的維護、培訓和以結果為導向的服務包的供應商，將更有利於留住那些能夠承受關稅主導的預算限制的機構客戶。

最後，監管和合規工作與關稅主導的策略選擇相互交織。尋求本地化供應的機構可能會在不同司法管轄區遇到不同的監管路徑和檢驗要求。因此，醫療機構必須儘早投資於監管策略和設計控制措施，以確保供應商或生產地點的變更不會損害臨床有效性或研究完整性。總體而言，關稅動態正在推動供應鏈向敏捷性、服務主導交付和在地化驗證工作轉變，這些因素共同影響採購和研發的優先事項。

透過對組件、技術、應用和最終用戶的細分洞察，揭示了不同的市場採納促進因素和產品開發重點。

組件級細分揭示了硬體、服務和軟體各自不同的價值促進因素。硬體投資優先考慮分析儀的準確性和可靠性、電極和感測器的靈敏度和生物相容性，以及掃描儀的吞吐量和影像保真度。諮詢、維護和培訓等服務是差異化因素，能夠降低整體擁有成本，並縮短臨床人員和研究團隊的熟練時間。軟體分為支援科學解讀的分析應用程式和確保安全、可擴展儲存以及符合監管要求的審核追蹤的資料管理解決方案。

科技碎片化凸顯了創新和應用壓力最大的領域。腦電圖（EEG）技術，包括攜帶式、固定式和無線式等多種形式，正引領傳統中心以外的資料擷取普及化。功能性磁振造影（fMRI）作為一種高解析度成像方式，繼續發揮其在臨床和研究工作流程中的作用；腦磁圖（MEG）技術則透過頭盔式系統和新興的穿戴式式設備不斷發展，降低了長期監測的門檻。近紅外光譜（NIRS）技術（包括連續波、頻域和時域成像）提供了互補的血流動力學資訊，儘管它們在空間解析度和深度靈敏度之間存在不同的權衡。正子斷層掃描（PET）成像，包括澱粉樣蛋白PET、FDG-PET和Tau蛋白PET，持續提供分子特異性訊息，這與神經退化疾病研究和腫瘤學應用密切相關。

應用細分區分了臨床和研究需求。神經病學、腫瘤學和精神病學等臨床應用需要檢驗、可重複的輸出結果，並將其整合到診斷流程和治療監測中。學術研究、認知神經科學和藥物研究等研究應用則需要靈活的實驗設計平台、高通量資料收集以及嚴格的溯源機制以確保結果的可重複性。最終用戶細分則闡明了應用採用的動態：學術研究機構優先考慮靈活性和新功能；醫院和診斷中心重視可靠性、合規性和臨床醫生工作流程；而製藥和生物技術公司則重視轉化應用的穩健性和數據互通性，以支持其藥物開發平臺。

這些細分視角為相關人員提供了一個框架，使他們能夠將產品藍圖、服務產品和打入市場策略與每項技術、應用和使用者群體的獨特需求保持一致。

美洲、歐洲、中東和非洲以及亞太地區的競爭和招募動態對採購、製造和合作研究策略產生影響。

區域動態對腦圖譜儀器的研發、應用和商業化有顯著影響，每個主要區域都各具特色，既有優勢也有限制因素。在美洲，完善的臨床基礎設施和集中的生物技術及製藥活動催生了對先進成像和電生理解決方案的需求，而充滿活力的研究生態系統則促進了快速的轉化合作。該地區還擁有成熟的製造群和創業投資網路，為創新提供支持，但公共醫療系統的採購週期可能較長。

歐洲、中東和非洲呈現出多元化的格局，嚴格的監管環境和強大的公共醫療體係有利於採用經過驗證的臨床工具和整合式服務。歐洲許多地區的卓越學術水平支持深入的研究夥伴關係和先進檢驗調查方法的標準化，而更廣泛區域內的新興中心正日益成為本地製造和提供經濟高效、性能可靠的設備的重要市場，以支持不斷擴展的診斷能力。

亞太地區正經歷可攜式和擴充性技術的快速普及，同時本地製造能力不斷提升，政府也大力支持數位醫療和醫療設備創新。大規模生產的醫療保健市場和不斷成長的研發投入，為兼顧成本效益的醫療器材策略和支援大規模研究的高階數據平台創造了機會。根據不同地區的具體情況，當地政策、報銷機制和人才儲備將影響新技術從早期應用到常規臨床應用的速度，而這些因素也將影響產品組合、定價和售後服務模式等方面的策略決策。

公司策略和競爭優勢專注於模組化硬體、高級分析、整合服務以及能夠推動設施長期採用的夥伴關係關係。

腦圖譜儀器領域的公司在多個方面實現差異化：模組化硬體、先進的軟體和全面的服務。領先的設備製造商專注於感測器性能、訊號保真度和符合人體工學的設計，以縮短設定時間並支援不同的研究人群。同時，以軟體為中心的供應商則強調可復現的流程、可解釋的機器學習和可互通的資料標準，以促進與電子健康記錄和實驗室系統的整合。

服務供應商正透過將諮詢、驗證和培訓與長期維護合約捆綁在一起，強化​​提案，從而圍繞執行時間和數據品質建立獎勵。設備製造商與雲端和分析公司之間的合作日益普遍，反映出企業正朝著以平台為中心的經營模式發展。新興企業經常推出顛覆性的硬體概念或專業分析技術，而現有企業則透過有針對性的收購、策略聯盟或加速內部互補能力的開發來應對。

投資人的關注和企業發展活動往往傾向於那些展現出監管敏銳度並能提供臨床或轉化價值證據的公司。能夠展現出強大的數據管治框架、完善的臨床合作夥伴生態系統以及涵蓋資本銷售到訂閱服務的靈活交付模式的公司，更有利於獲取多方相關人員的價值。最後，卓越的製造營運、供應鏈韌性和客戶支援往往決定客戶維繫，尤其是在服務連續性至關重要的臨床和診斷領域。

針對領導者可採取的行動建議，以加強供應鏈、投資數據平台並建立協作證據路徑，從而促進臨床應用的持續發展。

為因應地緣政治和關稅波動，產業領導者應優先考慮供應鏈韌性和模組化產品設計，以確保為臨床和科學研究客戶提供持續服務。投資本地組裝和建立策略供應商合作夥伴關係可以減少前置作業時間波動，並保護醫療機構免受突發成本衝擊。

領導者還必須加快對資料管理和分析平台的投資，以支援監管可追溯性和互通性工作流程。重視可復現的分析流程、追溯追蹤和隱私保護資料策略，將有助於與臨床應用和藥物研發專案開展合作。結合有針對性的服務，例如現場培訓、遠端維護和以結果為導向的諮詢，這些能力可以將業務關係轉化為策略性的長期合作關係。

與學術中心和臨床領導者進行策略合作至關重要，這有助於獲得臨床效用證據，並共同製定符合支付方和監管機構期望的方案。企業應探索靈活的商業模式，例如基於訂閱的准入和基於績效的定價，以降低資金緊張的診所採用該技術的門檻。最後，制定一項重點突出、能夠預見跨司法管轄區檢驗要求的監管策略，將加快產品部署並最大限度地減少返工，尤其對於計劃本地化生產或進入新地域市場的公司而言更是如此。

採用嚴謹的混合調查方法，結合相關人員訪談、監管機構調查和技術調查，以獲得可操作、可複製的洞見。

本執行執行摘要的調查方法融合了定性和結構化的證據收集技術，以確保其穩健性和有效性。主要研究包括對臨床醫生、首席研究員、採購負責人和設備工程師進行深度訪談，以了解操作實務、痛點和應用標準。此外，還對監管指南、技術標準和同行評審文獻進行了系統性回顧，以梳理檢驗路徑、安全考量和最佳方法實踐。

分析過程包括針對特定技術的應用映射，以匹配設備功能與臨床和研究需求；以及供應鏈映射，以識別採購風險和緩解措施。從最終用戶、製造商和服務供應商的觀點進行三角驗證，有助於檢驗結論並確保建議反映實際情況的限制。當新出現的證據或區域差異影響結論的普遍適用性時，我們會謹慎地記錄假設並揭露局限性。

本研究的資料管治優先考慮可追溯性和可重現性，並制定了結構化的訪談主題編碼和原始資訊歸檔通訊協定。在定量輸入有助於解讀情境的情況下，我們採取保守且透明的方法，避免過度強調確定性。總體而言，該方法旨在平衡深刻見解與臨床、研究和商業決策者的實際應用價值。

簡明結論總結了技術創新、服務模式和供應鏈動態的相互作用將如何塑造腦圖譜儀器。

腦圖譜儀器的發展軌跡呈現出快速的技術創新、不斷演進的服務模式以及不斷變化的供應鏈格局，這既為相關人員帶來了機遇，也帶來了挑戰。無論是硬體、軟體或服務，成功越來越依賴提供可互通、以數據為中心的解決方案，這些方案既要符合監管和臨床工作流程，又要為實際部署提供清晰的路徑。應用模式反映了高保真成像技術和新興可攜式技術之間的相互作用，而最成功的策略是將這些技術整合到靈活且有實證基礎的產品中。

區域和政策動態，包括貿易政策調整，凸顯了供應鏈敏捷性、在地檢驗和服務主導商業模式的重要性。積極透過模組化設計、資料管理投資和協作式證據產生來應對這些挑戰的研發機構，將能更好地滿足學術研究人員、臨床團隊和藥物研發人員的多元化需求。總之，最具韌性和影響力的公司，將是那些將卓越的技術能力與強大的支持體系和策略夥伴關係關係相結合，從而加速研究成果實用化的公司。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 可攜式腦電圖系統在遠端神經系統診斷和持續病患監測的應用日益廣泛
  • 將人工智慧演算法與神經影像數據結合，以提高腦圖譜繪製的準確性和預測分析能力。
  • 利用功能性近紅外線光譜技術開發用於臨床研究的穿戴式式腦監測設備
  • 擴展雲端基礎的神經數據平台，以支援神經科學研究中的即時協作和巨量資料分析
  • 監管核准和報銷框架，以推進醫院診斷性腦圖譜儀器的商業化
  • 消費級腦電圖頭戴裝置的興起，使得認知能力分析和神經回饋變得輕而易舉。
  • 結合腦電圖、腦磁圖和磁振造影的多模態腦造影技術取得了進展，提高了研究中的時空解析度。

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章腦圖譜儀器市場（按組件分類）

  • 硬體
    • 分析設備
    • 電極和感測器
    • 掃描器
  • 服務
    • 諮詢
    • 維護和培訓
  • 軟體
    • 分析軟體
    • 資料管理軟體

第9章腦圖譜儀器市場（依技術分類）

  • EEG
    • 可攜式腦電圖系統
    • 固定式腦電圖系統
    • 無線腦電圖系統
  • fMRI
    • 臨床功能性磁振造影
    • 研究功能性磁振造影
  • MEG
    • 頭盔式MEG
    • 穿戴式 MEG
  • NIRS
    • 連續波近紅外光譜
    • 頻域近紅外光譜
    • 時域近紅外光譜
  • PET
    • 澱粉樣蛋白PET
    • FDG-PET
    • Tau PET

第10章腦圖譜儀器市場（依應用領域分類）

  • 臨床
    • 神經病學
    • 腫瘤學
    • 精神病學
  • 研究
    • 學術研究
    • 認知神經科學
    • 藥物研究

第11章腦圖譜儀器市場（依最終用戶分類）

  • 學術研究機構
  • 醫院和診斷中心
  • 製藥和生物技術公司

第12章腦圖譜儀器市場（按地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章腦圖譜儀器市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國腦圖譜儀器市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Advanced Brain Monitoring, Inc
    • Brainlab AG
    • Siemens Healthineers AG
    • Shimadzu Corporation
    • Nihon Kohden Corporation
    • Medtronic PLC
    • SCANCO Medical AG
    • Koninklijke Philips NV
    • Cognionics, Inc.
    • GE Healthcare
Product Code: MRR-2214614772D1

The Brain Mapping Instruments Market is projected to grow by USD 5.15 billion at a CAGR of 14.37% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 1.75 billion
Estimated Year [2025] USD 2.01 billion
Forecast Year [2032] USD 5.15 billion
CAGR (%) 14.37%

A comprehensive introduction to the evolving ecosystem of brain mapping instruments addressing hardware, services, software, and end user interoperability

Brain mapping instruments occupy a pivotal role at the intersection of neuroscience research, clinical diagnostics, and therapeutic innovation. Contemporary instruments span a complex ecosystem of hardware, services, and software that together enable clinicians and researchers to visualize, quantify, and interpret neural activity across multiple spatial and temporal scales. As technological capabilities expand, instruments increasingly serve as platforms for multimodal integration, advanced analytics, and collaborative workflows that extend beyond isolated device deployment.

The hardware layer encompasses analysis equipment, electrodes and sensors, and scanning systems that must deliver precision, reliability, and compatibility with evolving analytical pipelines. Supporting services, including consulting and maintenance plus training programs, underpin successful adoption by ensuring operational continuity and maximized scientific yield. Software solutions range from analysis applications to data management systems designed to turn high-dimensional signals into reproducible, regulatory-grade outputs.

Across clinical and research contexts, user needs diverge but remain interconnected. Neurology, oncology, and psychiatry demand instruments that support diagnostic clarity and therapeutic monitoring, while academic research, cognitive neuroscience, and pharmaceutical research require flexible platforms for hypothesis-driven experimentation and translational studies. End users such as academic and research institutes, hospitals and diagnostic centers, and pharmaceutical and biotechnology companies each bring distinct procurement cycles, regulatory expectations, and data governance requirements.

Taken together, these dynamics underscore a shift from single-function devices toward interoperable, software-enabled systems that prioritize data integrity and lifecycle support. The introductory framing here sets the stage for deeper analysis of technology trajectories, supply chain pressures, regulatory considerations, and the strategic moves that will determine which solutions realize clinical and commercial impact.

An in-depth exploration of technological convergence, data-first platforms, and service-driven models reshaping brain mapping instrument adoption across clinical and research settings

The landscape for brain mapping instruments is undergoing transformative shifts driven by advances in miniaturization, real-time analytics, and human-centered design that expand where and how neural data can be collected. Portable and wireless EEG systems have redefined accessibility by enabling studies outside of traditional lab environments, while wearable magnetoencephalography and novel NIRS modalities are reducing barriers to longitudinal and ambulatory monitoring. These hardware innovations, paired with cloud-native data architectures and edge analytics, are ushering in a new era of contextual neuroscience where patient- and participant-centric workflows become feasible at scale.

Simultaneously, software is evolving from isolated analysis packages toward integrated platforms that combine advanced signal processing, machine learning, and secure data management. Analysis software now emphasizes reproducibility, provenance tracking, and regulatory readiness, and data management systems are adapting to stricter privacy expectations and federated learning models. As a result, services such as consulting, maintenance, and training increasingly focus on enabling institutions to operationalize complex instrument fleets and to extract longitudinal value from high-frequency data streams.

Another notable shift is the blurring of boundaries between clinical and research applications. Clinical fMRI and research fMRI workflows are converging through standardized protocols and interoperable data formats, while PET imaging subtypes are being integrated into multimodal studies that correlate metabolic signals with electrophysiological and hemodynamic measures. This convergence is fostering deeper collaborations between hospitals, academic centers, and pharmaceutical organizations, and it is accelerating the translation of experimental findings into diagnostic and therapeutic tools.

Finally, regulatory and reimbursement pressures are shaping product roadmaps. Manufacturers are prioritizing features that demonstrate clinical utility and that align with evidence frameworks used by payers and regulators. In parallel, supply chain resilience and localization strategies are becoming essential as geopolitical considerations influence sourcing and production decisions. Together, these shifts are redefining competitive advantage, moving it toward those organizations that combine device excellence with robust software ecosystems and end-to-end service capabilities.

A detailed analysis of how recent changes to trade policy and tariffs have altered supply chain choices, procurement models, and service priorities in brain mapping systems

Changes to tariff regimes and trade policy can ripple through the brain mapping ecosystem by affecting the availability, lead times, and cost profiles of critical components and finished systems. In scenarios where tariffs are applied to imported electronics, sensors, and imaging subsystems, manufacturers and procurement teams face pressure to reassess supply chains and to consider alternatives that reduce exposure to increased import costs. This often prompts accelerated conversations about supplier diversification, nearshoring of component production, and increased inventory buffering to ensure continuity for clinical and research customers.

The cumulative impact of tariff shifts in 2025 has been to elevate the strategic importance of manufacturing footprint and supplier relationships. Suppliers with vertically integrated capabilities or localized assembly facilities gain relative advantages because they can shield buyers from transit-related uncertainty and customs-related variability. Hospitals and research institutes, which typically operate on tight capital and procurement cycles, may adjust purchasing patterns to prioritize modular systems that allow incremental upgrades rather than full system replacements, thereby mitigating the price sensitivity introduced by higher import duties.

Tariffs also stimulate changes in contracting and service models. As capital expenditures become more complex to justify under higher component costs, many organizations will explore service-based procurement, extended leasing arrangements, and platform-as-a-service options to maintain access to leading-edge instrumentation without bearing the full upfront cost. Vendors that can provide comprehensive maintenance, training, and outcome-oriented service bundles are better positioned to retain institutional customers navigating tariff-driven budgetary constraints.

Lastly, regulatory and compliance efforts intersect with tariff-driven strategic choices. Institutions seeking to localize supply may encounter differing regulatory pathways and validation requirements across jurisdictions. Therefore, organizations must invest early in regulatory strategy and design controls to ensure that any changes in supplier or manufacturing location do not compromise clinical validity or research integrity. Overall, tariff dynamics are prompting a reorientation toward supply chain agility, service-led offerings, and localized validation efforts that collectively shape procurement and development priorities.

Targeted segmentation insights across components, technologies, applications, and end users that reveal differentiated adoption drivers and product development priorities

Component-level segmentation reveals divergent value drivers across hardware, services, and software. Hardware investments prioritize the precision and reliability of analysis equipment, the sensitivity and biocompatibility of electrodes and sensors, and the throughput and image fidelity of scanners. Services such as consulting and maintenance plus training become differentiators that reduce total cost of ownership and accelerate time-to-proficiency for clinical staff and research teams. Software divides into analysis applications that underpin scientific interpretation and data management solutions that ensure secure, scalable storage and regulatory-ready audit trails.

Technology segmentation clarifies where innovation and adoption pressures are most acute. EEG technologies, in their portable, stationary, and wireless forms, lead in democratizing data collection outside of traditional centers. fMRI retains its role as a high-resolution modality with distinct clinical and research workflows, while MEG is evolving through both helmet-based systems and emerging wearable formats that lower barriers to longitudinal monitoring. NIRS technologies-continuous wave, frequency domain, and time domain-offer complementary hemodynamic insights with varying trade-offs in spatial resolution and depth sensitivity. PET imaging, including amyloid PET, FDG-PET, and tau PET, continues to provide molecular specificity that intersects with neurodegenerative research and oncology applications.

Application segmentation differentiates clinical needs from research imperatives. Clinical deployments in neurology, oncology, and psychiatry demand validated, reproducible outputs that integrate into diagnostic pathways and therapeutic monitoring. Research applications across academic research, cognitive neuroscience, and pharmaceutical research require flexible platforms for experimental design, high-throughput data capture, and rigorous provenance for reproducibility. End-user segmentation underscores adoption dynamics: academic and research institutes prioritize flexibility and novel capabilities; hospitals and diagnostic centers emphasize reliability, regulatory compliance, and clinician workflows; and pharmaceutical and biotechnology companies focus on translational robustness and data interoperability for drug development pipelines.

Together, these segmentation lenses provide a framework for stakeholders to align product roadmaps, service offerings, and go-to-market strategies with the distinct needs of each technology, application, and user constituency.

Regional competitive and adoption dynamics across the Americas, Europe Middle East & Africa, and Asia-Pacific that influence procurement, manufacturing, and research collaboration strategies

Regional dynamics exert a powerful influence on the development, adoption, and commercialization of brain mapping instruments, with distinct strengths and constraints characterizing each major geography. In the Americas, robust clinical infrastructure and concentrated biotech and pharmaceutical activity create demand for sophisticated imaging and electrophysiology solutions, while a vibrant research ecosystem fosters rapid translational collaborations. This region also features established manufacturing clusters and venture capital networks that support innovation, though procurement cycles in public health systems can be lengthy.

Europe, Middle East & Africa presents a diverse landscape where regulatory rigor and strong public healthcare systems drive a preference for validated clinical tools and integrated service offerings. Academic excellence across many European centers sustains deep research partnerships and high levels of methodological standardization. Meanwhile, emerging hubs within the broader region are increasingly important for localized manufacturing and as markets for cost-effective, robust instruments that support expanding diagnostic capabilities.

Asia-Pacific combines rapid adoption of portable and scalable technologies with growing in-region manufacturing capacity and government-backed initiatives that prioritize digital health and medical device innovation. High-volume healthcare markets and expanding research investment create opportunities for both cost-efficient device strategies and premium, data-rich platforms that support large-scale studies. Across regions, local policy, reimbursement frameworks, and talent availability influence how quickly new modalities move from early adoption to routine clinical use, and these factors should inform strategic decisions about product configuration, pricing, and post-sales service models.

Company strategies and competitive differentiators focused on modular hardware, advanced analytics, integrated services, and partnerships that drive long-term institutional adoption

Companies operating in the brain mapping instrument space are differentiating along multiple vectors, including hardware modularity, software sophistication, and depth of service offerings. Leading-edge device suppliers focus on sensor performance, signal fidelity, and ergonomic design to reduce setup time and to support diverse study populations. Concurrently, software-focused providers emphasize reproducible pipelines, explainable machine learning, and interoperable data standards that ease integration with electronic health records and laboratory systems.

Service providers are enhancing their propositions by bundling consulting, validation, and training with long-term maintenance contracts that align incentives around uptime and data quality. Alliances between device manufacturers and cloud or analytics firms are increasingly common, reflecting a move toward platform-centric business models. Startups frequently introduce disruptive hardware concepts or specialized analytics, and incumbent firms respond through targeted acquisitions, strategic partnerships, or by accelerating internal development of complementary capabilities.

Investor attention and corporate development activity tend to favor companies that demonstrate regulatory acumen and the ability to deliver evidence of clinical or translational value. Firms that can show robust data governance frameworks, an ecosystem of clinical partners, and flexible delivery models-ranging from capital sales to subscription services-are better positioned to capture multi-stakeholder value. Finally, operational excellence in manufacturing, supply chain resilience, and customer support often determines long-term customer retention, especially in clinical and diagnostic settings where continuity of service is paramount.

Actionable recommendations for leaders to strengthen supply chains, invest in data platforms, and build collaborative evidence pathways that enable sustained clinical adoption

Industry leaders should prioritize supply chain resilience and modular product design to buffer against geopolitical and tariff-related disruptions, thereby ensuring continuity of service for clinical and research customers. Investing in localized assembly or strategic supplier partnerships can reduce lead-time volatility and protect institutions from sudden cost shocks, while modular hardware architectures enable incremental upgrades that extend device lifecycles and protect customer procurement budgets.

Leaders must also accelerate investment in data management and analysis platforms that support regulatory traceability and interoperable workflows. Emphasizing reproducible analysis pipelines, provenance tracking, and privacy-preserving data strategies will facilitate clinical adoption and partnerships with pharmaceutical research programs. Coupled with targeted service offerings-such as on-site training, remote maintenance, and outcome-oriented consulting-these capabilities can convert transactional relationships into strategic long-term engagements.

Strategic collaboration with academic centers and clinical leaders is essential to generate evidence of clinical utility and to co-develop protocols that align with payer and regulatory expectations. Companies should explore flexible commercial models, including subscription-based access and outcome-tied pricing, to lower adoption barriers for cash-constrained institutions. Finally, a focused regulatory strategy that anticipates cross-jurisdictional validation requirements will reduce time to deployment and minimize rework, particularly for organizations planning to localize manufacturing or to enter new regional markets.

A rigorous mixed-methods research methodology combining stakeholder interviews, regulatory review, and technology mapping to produce actionable and reproducible insights

The research methodology underpinning this executive summary integrates qualitative and structured evidence-gathering techniques to ensure robustness and relevance. Primary inputs include in-depth interviews with clinicians, research directors, procurement officers, and device engineers to capture operational realities, pain points, and adoption criteria. These insights are supplemented by a systematic review of regulatory guidance, technical standards, and peer-reviewed literature to map validation pathways, safety considerations, and methodological best practices.

Analytical processes involve technology-by-application mapping to align device capabilities with clinical and research requirements, as well as supply chain mapping to identify sourcing risks and mitigation opportunities. Triangulation across perspectives-end users, manufacturers, and service providers-helps to validate conclusions and to ensure that recommendations reflect real-world constraints. Care is taken to document assumptions and to disclose limitations where evidence is emerging or where regional heterogeneity affects generalizability.

Data governance for the study prioritizes traceability and reproducibility, with structured protocols for coding interview themes and for archiving primary sources. Where quantitative inputs inform scenario interpretation, conservative and transparent approaches are applied to avoid overstating certainty. The overall approach aims to balance depth of insight with practical applicability for decision-makers across clinical, research, and commercial functions.

A concise conclusion summarizing the interplay of technological innovation, service models, and supply chain dynamics that will shape the future of brain mapping instruments

The trajectory of brain mapping instruments is characterized by rapid technological advances, evolving service models, and shifting supply chain realities that together create both opportunity and complexity for stakeholders. Across hardware, software, and services, success increasingly depends on delivering interoperable, data-centric solutions that respect regulatory and clinical workflows while providing clear pathways to operational deployment. Adoption patterns reflect the interplay between high-fidelity modalities and emerging portable formats, and the most successful strategies weave these modalities into flexible, evidence-backed offerings.

Regional and policy dynamics, including trade policy adjustments, have underscored the importance of supply chain agility, localized validation, and service-led commercial models. Organizations that proactively address these dimensions through modular design, investment in data management, and collaborative evidence generation will be better placed to meet the diverse needs of academic researchers, clinical teams, and pharmaceutical developers. In sum, the most resilient and impactful players will be those that blend technical excellence with robust support structures and strategic partnerships that accelerate translation from research to clinical utility.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Increasing adoption of portable EEG systems for remote neurological diagnostics and continuous patient monitoring
  • 5.2. Integration of artificial intelligence algorithms with neuroimaging data to enhance brain mapping accuracy and predictive analytics
  • 5.3. Development of wearable brain monitoring devices using functional near infrared spectroscopy technology in clinical research
  • 5.4. Expansion of cloud based neuro data platforms for real time collaboration and big data analysis in neuroscience studies
  • 5.5. Regulatory approvals and reimbursement frameworks driving the commercialization of diagnostic brain mapping instruments in hospitals
  • 5.6. Rise of direct to consumer brain mapping headsets offering accessible cognitive performance insights and neurofeedback
  • 5.7. Advancements in multimodal brain mapping combining EEG, MEG, and MRI to improve spatial temporal resolution in research

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Brain Mapping Instruments Market, by Component

  • 8.1. Hardware
    • 8.1.1. Analysis Equipment
    • 8.1.2. Electrodes & Sensors
    • 8.1.3. Scanners
  • 8.2. Services
    • 8.2.1. Consulting
    • 8.2.2. Maintenance & Training
  • 8.3. Software
    • 8.3.1. Analysis Software
    • 8.3.2. Data Management Software

9. Brain Mapping Instruments Market, by Technology

  • 9.1. EEG
    • 9.1.1. Portable EEG Systems
    • 9.1.2. Stationary EEG Systems
    • 9.1.3. Wireless EEG Systems
  • 9.2. fMRI
    • 9.2.1. Clinical fMRI
    • 9.2.2. Research fMRI
  • 9.3. MEG
    • 9.3.1. Helmet-Based MEG
    • 9.3.2. Wearable MEG
  • 9.4. NIRS
    • 9.4.1. Continuous Wave NIRS
    • 9.4.2. Frequency Domain NIRS
    • 9.4.3. Time Domain NIRS
  • 9.5. PET
    • 9.5.1. Amyloid PET
    • 9.5.2. FDG-PET
    • 9.5.3. Tau PET

10. Brain Mapping Instruments Market, by Application

  • 10.1. Clinical
    • 10.1.1. Neurology
    • 10.1.2. Oncology
    • 10.1.3. Psychiatry
  • 10.2. Research
    • 10.2.1. Academic Research
    • 10.2.2. Cognitive Neuroscience
    • 10.2.3. Pharmaceutical Research

11. Brain Mapping Instruments Market, by End User

  • 11.1. Academic & Research Institutes
  • 11.2. Hospitals & Diagnostic Centers
  • 11.3. Pharmaceutical & Biotechnology Companies

12. Brain Mapping Instruments Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Brain Mapping Instruments Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Brain Mapping Instruments Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Advanced Brain Monitoring, Inc
    • 15.3.2. Brainlab AG
    • 15.3.3. Siemens Healthineers AG
    • 15.3.4. Shimadzu Corporation
    • 15.3.5. Nihon Kohden Corporation
    • 15.3.6. Medtronic PLC
    • 15.3.7. SCANCO Medical AG
    • 15.3.8. Koninklijke Philips N.V.
    • 15.3.9. Cognionics, Inc.
    • 15.3.10. GE Healthcare

LIST OF FIGURES

  • FIGURE 1. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COMPONENT, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRAIN MAPPING INSTRUMENTS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. BRAIN MAPPING INSTRUMENTS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. BRAIN MAPPING INSTRUMENTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY HARDWARE, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY HARDWARE, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY HARDWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY HARDWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY HARDWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY HARDWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY HARDWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY HARDWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ANALYSIS EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ANALYSIS EQUIPMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ANALYSIS EQUIPMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ANALYSIS EQUIPMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ANALYSIS EQUIPMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ANALYSIS EQUIPMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ELECTRODES & SENSORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ELECTRODES & SENSORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ELECTRODES & SENSORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ELECTRODES & SENSORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ELECTRODES & SENSORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ELECTRODES & SENSORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SCANNERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SCANNERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SCANNERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SCANNERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SCANNERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SCANNERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CONSULTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CONSULTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CONSULTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CONSULTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CONSULTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CONSULTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY MAINTENANCE & TRAINING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY MAINTENANCE & TRAINING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY MAINTENANCE & TRAINING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY MAINTENANCE & TRAINING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY MAINTENANCE & TRAINING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY MAINTENANCE & TRAINING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SOFTWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SOFTWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ANALYSIS SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ANALYSIS SOFTWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ANALYSIS SOFTWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ANALYSIS SOFTWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ANALYSIS SOFTWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ANALYSIS SOFTWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY EEG, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY EEG, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY EEG, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY EEG, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY EEG, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY EEG, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY EEG, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY EEG, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PORTABLE EEG SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PORTABLE EEG SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PORTABLE EEG SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PORTABLE EEG SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PORTABLE EEG SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PORTABLE EEG SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY STATIONARY EEG SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY STATIONARY EEG SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY STATIONARY EEG SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY STATIONARY EEG SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY STATIONARY EEG SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY STATIONARY EEG SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY WIRELESS EEG SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY WIRELESS EEG SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY WIRELESS EEG SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY WIRELESS EEG SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY WIRELESS EEG SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY WIRELESS EEG SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY FMRI, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY FMRI, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY FMRI, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY FMRI, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY FMRI, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY FMRI, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY FMRI, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY FMRI, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CLINICAL FMRI, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CLINICAL FMRI, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CLINICAL FMRI, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CLINICAL FMRI, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CLINICAL FMRI, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CLINICAL FMRI, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY RESEARCH FMRI, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY RESEARCH FMRI, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY RESEARCH FMRI, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY RESEARCH FMRI, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY RESEARCH FMRI, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY RESEARCH FMRI, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY MEG, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY MEG, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY MEG, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY MEG, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY MEG, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY MEG, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY MEG, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY MEG, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY HELMET-BASED MEG, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY HELMET-BASED MEG, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY HELMET-BASED MEG, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY HELMET-BASED MEG, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY HELMET-BASED MEG, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY HELMET-BASED MEG, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY WEARABLE MEG, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY WEARABLE MEG, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY WEARABLE MEG, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY WEARABLE MEG, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY WEARABLE MEG, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY WEARABLE MEG, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY NIRS, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY NIRS, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY NIRS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY NIRS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY NIRS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY NIRS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY NIRS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY NIRS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CONTINUOUS WAVE NIRS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CONTINUOUS WAVE NIRS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CONTINUOUS WAVE NIRS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CONTINUOUS WAVE NIRS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CONTINUOUS WAVE NIRS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CONTINUOUS WAVE NIRS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY FREQUENCY DOMAIN NIRS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY FREQUENCY DOMAIN NIRS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY FREQUENCY DOMAIN NIRS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY FREQUENCY DOMAIN NIRS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY FREQUENCY DOMAIN NIRS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY FREQUENCY DOMAIN NIRS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY TIME DOMAIN NIRS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY TIME DOMAIN NIRS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY TIME DOMAIN NIRS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY TIME DOMAIN NIRS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY TIME DOMAIN NIRS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY TIME DOMAIN NIRS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PET, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PET, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PET, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PET, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PET, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PET, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PET, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PET, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY AMYLOID PET, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY AMYLOID PET, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY AMYLOID PET, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY AMYLOID PET, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY AMYLOID PET, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY AMYLOID PET, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY FDG-PET, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY FDG-PET, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY FDG-PET, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY FDG-PET, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY FDG-PET, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY FDG-PET, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY TAU PET, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY TAU PET, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY TAU PET, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY TAU PET, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY TAU PET, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY TAU PET, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CLINICAL, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CLINICAL, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CLINICAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CLINICAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CLINICAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CLINICAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CLINICAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CLINICAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY NEUROLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY NEUROLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ONCOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PSYCHIATRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PSYCHIATRY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PSYCHIATRY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PSYCHIATRY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PSYCHIATRY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PSYCHIATRY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY RESEARCH, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY RESEARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY RESEARCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY RESEARCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY RESEARCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ACADEMIC RESEARCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ACADEMIC RESEARCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ACADEMIC RESEARCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ACADEMIC RESEARCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COGNITIVE NEUROSCIENCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COGNITIVE NEUROSCIENCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COGNITIVE NEUROSCIENCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COGNITIVE NEUROSCIENCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COGNITIVE NEUROSCIENCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COGNITIVE NEUROSCIENCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PHARMACEUTICAL RESEARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PHARMACEUTICAL RESEARCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PHARMACEUTICAL RESEARCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PHARMACEUTICAL RESEARCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PHARMACEUTICAL RESEARCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PHARMACEUTICAL RESEARCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 269. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 270. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 271. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 272. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 273. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY HARDWARE, 2018-2024 (USD MILLION)
  • TABLE 274. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY HARDWARE, 2025-2032 (USD MILLION)
  • TABLE 275. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 276. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 277. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 278. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 279. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 280. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 281. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY EEG, 2018-2024 (USD MILLION)
  • TABLE 282. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY EEG, 2025-2032 (USD MILLION)
  • TABLE 283. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY FMRI, 2018-2024 (USD MILLION)
  • TABLE 284. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY FMRI, 2025-2032 (USD MILLION)
  • TABLE 285. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY MEG, 2018-2024 (USD MILLION)
  • TABLE 286. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY MEG, 2025-2032 (USD MILLION)
  • TABLE 287. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY NIRS, 2018-2024 (USD MILLION)
  • TABLE 288. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY NIRS, 2025-2032 (USD MILLION)
  • TABLE 289. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PET, 2018-2024 (USD MILLION)
  • TABLE 290. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PET, 2025-2032 (USD MILLION)
  • TABLE 291. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 292. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 293. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CLINICAL, 2018-2024 (USD MILLION)
  • TABLE 294. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CLINICAL, 2025-2032 (USD MILLION)
  • TABLE 295. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 296. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY RESEARCH, 2025-2032 (USD MILLION)
  • TABLE 297. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 298. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 299. NORTH AMERICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 300. NORTH AMERICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 301. NORTH AMERICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 302. NORTH AMERICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 303. NORTH AMERICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY HARDWARE, 2018-2024 (USD MILLION)
  • TABLE 304. NORTH AMERICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY HARDWARE, 2025-2032 (USD MILLION)
  • TABLE 305. NORTH AMERICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 306. NORTH AMERICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 307. NORTH AMERICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SOFTW